Skip to main content

News - Page 366 of 382

[In German:] MedUni Wien Studie klärt Ursachen des akuten Nierentransplantatversagens

[In German:] (Wien, 30-08-2010) Bei rund einem Viertel aller Nierentransplantationen von  verstorbenen Organspendern funktioniert das Transplantat...

Ozone increases allergy potential of rye

Study of the Medical University of Vienna and the Austrian Institute of Technology shows a connection between increasing ozone content and rise in...

Lung cancer: Approach for new combined treatment

(Vienna, 23 August 2010) One reason for the frequent failure of innovative chemotherapies for treating lung cancer has been discovered by an...

[In German:] Spezialausgabe von „RNA Biology“ unter der Leitung von Andrea Barta

[In German:] (Wien, 23-08-2010) Eine von Univ. Prof.in Dr.in Andrea Barta (Max F. Perutz Laboratories der MedUni Wien) gemeinsam mit Univ. Prof. Dr....

[In German:] Prof. Dr. Werner Brannath erhält Professur in Bremen

[In German:] (Wien, 19-08-2010) Anfang August trat Ao.Univ. Prof. Mag. Dr. Werner Brannath vom Institut für Medizinische Statistik des Zentrums für...

Multi-resistant bacteria can be prevented

To prevent or curb the occurrence of multi-resistant bacteria, doctors need to act responsibly when using wide-spectrum antibiotics. Excessive doses...

[In German:] Informationsoffensive Mastozytose

[In German:] (Wien, 16-08-2010) Die Mastozytose ist eine nicht heilbare Erkrankung, die oft jahrzehntelang gutartig verläuft und kaum zu...

Atherosclerosis from the slightest exposure to lead

Even in quantities well below the guidelines, lead damages health and is a serious risk factor for cardiovascular diseases. In their research,...

MedUni Vienna pioneer in postgraduate university courses

With university courses in Gender Medicine and Traditional Chinese Medicine, MedUni Vienna is setting new landmarks in the European university...

Fabien Martins new managing director of Max F. Perutz Laboratories

(Vienna, 3 August 2010) As of 1 August 2010, Fabien Martins (41) will take over commercial management of Max F. Perutz Laboratories (MFPL), a...